| 1 | [SID49666851] | Active | AC50 | 1.003 | C-LANA FP assay Measured in Biochemical System Using Plate Reader - 2117-01_Inhibitor_Dose_CherryPick_Activity [AID504725, Type: confirmatory] | LANA [Human herpesvirus 8] [gi:312275222] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 49666851 | | CID | 9642859 | | Outcome | Active | | AC50 | 1.003 [uM] | | BioAssay | C-LANA FP assay Measured in Biochemical System Using Plate Reader - 2117-01_Inhibitor_Dose_CherryPick_Activity | | AID | 504725 | | BioAssay type | confirmatory | | Target | LANA [Human herpesvirus 8] [gi:312275222] | | PubMed | | | Data Table |  |
|
| 2 | [SID49666851] | Active | AC50 | 4.283 | C-LANA Counter Screen: DNA intercalators Measured in Biochemical System Using Plate Reader - 2117-02_Inhibitor_Dose_CherryPick_Activity_Set2 [AID504727, Type: confirmatory] | LANA [Human herpesvirus 8] [gi:312275222] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 49666851 | | CID | 9642859 | | Outcome | Active | | AC50 | 4.283 [uM] | | BioAssay | C-LANA Counter Screen: DNA intercalators Measured in Biochemical System Using Plate Reader - 2117-02_Inhibitor_Dose_CherryPick_Activity_Set2 | | AID | 504727 | | BioAssay type | confirmatory | | Target | LANA [Human herpesvirus 8] [gi:312275222] | | PubMed | | | Data Table |  |
|
| 3 | [SID49666851] | Active | IC50 | 6.945 | Epi-absorbance-based dose response assay for common IMP-1 and VIM-2 inhibitors: biochemical high throughput counterscreen to identify inhibitors of TEM-1 metallo-beta-lactamase [AID2755, Type: confirmatory] | Beta lactamase [Pseudomonas aeruginosa] [gi:114881106] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 49666851 | | CID | 9642859 | | Outcome | Active | | IC50 | 6.945 [uM] | | BioAssay | Epi-absorbance-based dose response assay for common IMP-1 and VIM-2 inhibitors: biochemical high throughput counterscreen to identify inhibitors of TEM-1 metallo-beta-lactamase | | AID | 2755 | | BioAssay type | confirmatory | | Target | Beta lactamase [Pseudomonas aeruginosa] [gi:114881106] | | PubMed | | | Data Table |  |
|
| 4 | [SID49666851] | Active | IC50 | 8.927 | Epi-absorbance-based dose response assay for common IMP-1 and VIM-2 inhibitors: biochemical high throughput screening assay to identify inhibitors of IMP-1metallo-beta-lactamase [AID2756, Type: confirmatory] | metallo-beta-lactamase IMP-1 [Pseudomonas aeruginosa] [gi:27368096] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 49666851 | | CID | 9642859 | | Outcome | Active | | IC50 | 8.927 [uM] | | BioAssay | Epi-absorbance-based dose response assay for common IMP-1 and VIM-2 inhibitors: biochemical high throughput screening assay to identify inhibitors of IMP-1metallo-beta-lactamase | | AID | 2756 | | BioAssay type | confirmatory | | Target | metallo-beta-lactamase IMP-1 [Pseudomonas aeruginosa] [gi:27368096] | | PubMed | | | Data Table |  |
|
| 5 | [SID49666851] | Active | IC50 | 9.4 | Epi-absorbance-based dose response assay for common IMP-1 and VIM-2 inhibitors: biochemical high throughput screening assay to identify inhibitors of VIM-2 metallo-beta-lactamase [AID2754, Type: confirmatory] | metallo beta-lactamase [Pseudomonas aeruginosa] [gi:7381449] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 49666851 | | CID | 9642859 | | Outcome | Active | | IC50 | 9.4 [uM] | | BioAssay | Epi-absorbance-based dose response assay for common IMP-1 and VIM-2 inhibitors: biochemical high throughput screening assay to identify inhibitors of VIM-2 metallo-beta-lactamase | | AID | 2754 | | BioAssay type | confirmatory | | Target | metallo beta-lactamase [Pseudomonas aeruginosa] [gi:7381449] | | PubMed | | | Data Table |  |
|
| 6 | [SID49666851] | Active | IC50 | 9.4 | Epi-absorbance-based dose response assay for common IMP-1 and VIM-2 inhibitors: biochemical high throughput screening assay to identify inhibitors of VIM-2 metallo-beta-lactamase [AID2754, Type: confirmatory] | metallo beta-lactamase [Pseudomonas aeruginosa] [gi:7381449] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 49666851 | | CID | 9642859 | | Outcome | Active | | IC50 | 9.4 [uM] | | BioAssay | Epi-absorbance-based dose response assay for common IMP-1 and VIM-2 inhibitors: biochemical high throughput screening assay to identify inhibitors of VIM-2 metallo-beta-lactamase | | AID | 2754 | | BioAssay type | confirmatory | | Target | metallo beta-lactamase [Pseudomonas aeruginosa] [gi:7381449] | | PubMed | | | Data Table |  |
|
| 7 | [SID49666851] | Active | Potency | 22.3872 | qHTS for Inhibitors of Vif-A3F Interactions: qHTS [AID602313, Type: confirmatory] | APOBEC3F gene product [Homo sapiens] [gi:22907044] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 49666851 | | CID | 9642859 | | Outcome | Active | | Potency | 22.3872 [uM] | | BioAssay | qHTS for Inhibitors of Vif-A3F Interactions: qHTS | | AID | 602313 | | BioAssay type | confirmatory | | Target | APOBEC3F gene product [Homo sapiens] [gi:22907044] | | PubMed | | | Data Table |  |
|
| 8 | [SID49666851] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of GLD-1 protein - TGE RNA interaction. [AID2280, Type: screening] | defective in Germ Line Development family member (gld-1) [Caenorhabditis elegans] [gi:17507875] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 49666851 | | CID | 9642859 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of GLD-1 protein - TGE RNA interaction. | | AID | 2280 | | BioAssay type | screening | | Target | defective in Germ Line Development family member (gld-1) [Caenorhabditis elegans] [gi:17507875] | | PubMed | | | Data Table |  |
|
| 9 | [SID49666851] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. [AID2057, Type: screening] | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 49666851 | | CID | 9642859 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. | | AID | 2057 | | BioAssay type | screening | | Target | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] | | PubMed | | | Data Table |  |
|
| 10 | [SID49666851] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. [AID2057, Type: screening] | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 49666851 | | CID | 9642859 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. | | AID | 2057 | | BioAssay type | screening | | Target | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] | | PubMed | | | Data Table |  |
|
| 11 | [SID49666851] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. [AID2057, Type: screening] | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 49666851 | | CID | 9642859 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. | | AID | 2057 | | BioAssay type | screening | | Target | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] | | PubMed | | | Data Table |  |
|
| 12 | [SID49666851] | Active | | | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. [AID2168, Type: screening] | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 49666851 | | CID | 9642859 | | Outcome | Active | | BioAssay | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. | | AID | 2168 | | BioAssay type | screening | | Target | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] | | PubMed | | | Data Table |  |
|
| 13 | [SID49666851] | Active | | | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. [AID2168, Type: screening] | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 49666851 | | CID | 9642859 | | Outcome | Active | | BioAssay | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. | | AID | 2168 | | BioAssay type | screening | | Target | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] | | PubMed | | | Data Table |  |
|
| 14 | [SID49666851] | Active | | | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. [AID2168, Type: screening] | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 49666851 | | CID | 9642859 | | Outcome | Active | | BioAssay | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. | | AID | 2168 | | BioAssay type | screening | | Target | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] | | PubMed | | | Data Table |  |
|
| 15 | [SID49666851] | Active | | | Primary cell-based high-throughput screening assay for identification of compounds that potentiate/activate regulator of G-protein signaling 4 (RGS4) [AID463111, Type: screening] | RGS4 gene product [Homo sapiens] [gi:5032039] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 49666851 | | CID | 9642859 | | Outcome | Active | | BioAssay | Primary cell-based high-throughput screening assay for identification of compounds that potentiate/activate regulator of G-protein signaling 4 (RGS4) | | AID | 463111 | | BioAssay type | screening | | Target | RGS4 gene product [Homo sapiens] [gi:5032039] | | PubMed | | | Data Table |  |
|
| 16 | [SID49666851] | Active | | | Primary cell-based high-throughput screening assay for identification of compounds that potentiate/activate regulator of G-protein signaling 4 (RGS4) [AID463111, Type: screening] | RGS4 gene product [Homo sapiens] [gi:5032039] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 49666851 | | CID | 9642859 | | Outcome | Active | | BioAssay | Primary cell-based high-throughput screening assay for identification of compounds that potentiate/activate regulator of G-protein signaling 4 (RGS4) | | AID | 463111 | | BioAssay type | screening | | Target | RGS4 gene product [Homo sapiens] [gi:5032039] | | PubMed | | | Data Table |  |
|
| 17 | [SID49666851] | Active | | | Primary cell-based high-throughput screening assay for identification of compounds that potentiate/activate regulator of G-protein signaling 4 (RGS4) [AID463111, Type: screening] | RGS4 gene product [Homo sapiens] [gi:5032039] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 49666851 | | CID | 9642859 | | Outcome | Active | | BioAssay | Primary cell-based high-throughput screening assay for identification of compounds that potentiate/activate regulator of G-protein signaling 4 (RGS4) | | AID | 463111 | | BioAssay type | screening | | Target | RGS4 gene product [Homo sapiens] [gi:5032039] | | PubMed | | | Data Table |  |
|
| 18 | [SID49666851] | Active | | | Epi-absorbance-based confirmation assay for common IMP-1 and VIM-2 inhibitors: biochemical high throughput screening assay to identify inhibitors of IMP-1 metallo-beta-lactamase. [AID2189, Type: screening] | metallo-beta-lactamase IMP-1 [Pseudomonas aeruginosa] [gi:27368096] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 49666851 | | CID | 9642859 | | Outcome | Active | | BioAssay | Epi-absorbance-based confirmation assay for common IMP-1 and VIM-2 inhibitors: biochemical high throughput screening assay to identify inhibitors of IMP-1 metallo-beta-lactamase. | | AID | 2189 | | BioAssay type | screening | | Target | metallo-beta-lactamase IMP-1 [Pseudomonas aeruginosa] [gi:27368096] | | PubMed | | | Data Table |  |
|
| 19 | [SID49666851] | Active | | | Epi-absorbance primary biochemical high throughput screening assay to identify inhibitors of IMP-1 metallo-beta-lactamase [AID1556, Type: screening] | metallo-beta-lactamase IMP-1 [Pseudomonas aeruginosa] [gi:27368096] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 49666851 | | CID | 9642859 | | Outcome | Active | | BioAssay | Epi-absorbance primary biochemical high throughput screening assay to identify inhibitors of IMP-1 metallo-beta-lactamase | | AID | 1556 | | BioAssay type | screening | | Target | metallo-beta-lactamase IMP-1 [Pseudomonas aeruginosa] [gi:27368096] | | PubMed | | | Data Table |  |
|
| 20 | [SID49666851] | Active | | | uHTS identification of agonists of the CRF-binding protein and CRF-R2 receptor complex [AID588473, Type: screening] | corticotropin releasing factor-binding protein [Homo sapiens] [gi:30219] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 49666851 | | CID | 9642859 | | Outcome | Active | | BioAssay | uHTS identification of agonists of the CRF-binding protein and CRF-R2 receptor complex | | AID | 588473 | | BioAssay type | screening | | Target | corticotropin releasing factor-binding protein [Homo sapiens] [gi:30219] | | PubMed | | | Data Table |  |
|
| 21 | [SID49666851] | Active | | | uHTS identification of agonists of the CRF-binding protein and CRF-R2 receptor complex [AID588473, Type: screening] | corticotropin releasing factor-binding protein [Homo sapiens] [gi:30219] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 49666851 | | CID | 9642859 | | Outcome | Active | | BioAssay | uHTS identification of agonists of the CRF-binding protein and CRF-R2 receptor complex | | AID | 588473 | | BioAssay type | screening | | Target | corticotropin releasing factor-binding protein [Homo sapiens] [gi:30219] | | PubMed | | | Data Table |  |
|
| 22 | [SID49666851] | Active | | | Allosteric Agonists of the Human D1 Dopamine Receptor: qHTS [AID504660, Type: screening] | D(1A) dopamine receptor [Homo sapiens] [gi:4503383] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 49666851 | | CID | 9642859 | | Outcome | Active | | BioAssay | Allosteric Agonists of the Human D1 Dopamine Receptor: qHTS | | AID | 504660 | | BioAssay type | screening | | Target | D(1A) dopamine receptor [Homo sapiens] [gi:4503383] | | PubMed | | | Data Table |  |
|
| 23 | [SID49666851] | Active | | | Allosteric Agonists of the Human D1 Dopamine Receptor: qHTS [AID504660, Type: screening] | D(1A) dopamine receptor [Homo sapiens] [gi:4503383] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 49666851 | | CID | 9642859 | | Outcome | Active | | BioAssay | Allosteric Agonists of the Human D1 Dopamine Receptor: qHTS | | AID | 504660 | | BioAssay type | screening | | Target | D(1A) dopamine receptor [Homo sapiens] [gi:4503383] | | PubMed | | | Data Table |  |
|
| 24 | [SID49666851] | Active | | | Allosteric Agonists of the Human D1 Dopamine Receptor: qHTS [AID504660, Type: screening] | D(1A) dopamine receptor [Homo sapiens] [gi:4503383] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 49666851 | | CID | 9642859 | | Outcome | Active | | BioAssay | Allosteric Agonists of the Human D1 Dopamine Receptor: qHTS | | AID | 504660 | | BioAssay type | screening | | Target | D(1A) dopamine receptor [Homo sapiens] [gi:4503383] | | PubMed | | | Data Table |  |
|
| 25 | [SID49666851] | Active | | | Allosteric Agonists of the Human D1 Dopamine Receptor: qHTS [AID504660, Type: screening] | D(1A) dopamine receptor [Homo sapiens] [gi:4503383] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 49666851 | | CID | 9642859 | | Outcome | Active | | BioAssay | Allosteric Agonists of the Human D1 Dopamine Receptor: qHTS | | AID | 504660 | | BioAssay type | screening | | Target | D(1A) dopamine receptor [Homo sapiens] [gi:4503383] | | PubMed | | | Data Table |  |
|
| 26 | [SID49666851] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) [AID434989, Type: screening] | orexin receptor type 1 [Homo sapiens] [gi:222080095] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 49666851 | | CID | 9642859 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) | | AID | 434989 | | BioAssay type | screening | | Target | orexin receptor type 1 [Homo sapiens] [gi:222080095] | | PubMed | | | Data Table |  |
|
| 27 | [SID49666851] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) [AID434989, Type: screening] | orexin receptor type 1 [Homo sapiens] [gi:222080095] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 49666851 | | CID | 9642859 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) | | AID | 434989 | | BioAssay type | screening | | Target | orexin receptor type 1 [Homo sapiens] [gi:222080095] | | PubMed | | | Data Table |  |
|
| 28 | [SID49666851] | Active | | | Primary biochemical high throughput screening assay to identify inhibitors of BCL2-related protein, long isoform (BCLXL). [AID2129, Type: screening] | bcl-xL [Homo sapiens] [gi:510901] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 49666851 | | CID | 9642859 | | Outcome | Active | | BioAssay | Primary biochemical high throughput screening assay to identify inhibitors of BCL2-related protein, long isoform (BCLXL). | | AID | 2129 | | BioAssay type | screening | | Target | bcl-xL [Homo sapiens] [gi:510901] | | PubMed | | | Data Table |  |
|
| 29 | [SID49666851] | Active | | | Primary biochemical high throughput screening assay to identify inhibitors of BCL2-related protein, long isoform (BCLXL). [AID2129, Type: screening] | bcl-xL [Homo sapiens] [gi:510901] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 49666851 | | CID | 9642859 | | Outcome | Active | | BioAssay | Primary biochemical high throughput screening assay to identify inhibitors of BCL2-related protein, long isoform (BCLXL). | | AID | 2129 | | BioAssay type | screening | | Target | bcl-xL [Homo sapiens] [gi:510901] | | PubMed | | | Data Table |  |
|
| 30 | [SID49666851] | Active | | | Primary biochemical high throughput screening assay to identify inhibitors of BCL2-related protein, long isoform (BCLXL). [AID2129, Type: screening] | bcl-xL [Homo sapiens] [gi:510901] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 49666851 | | CID | 9642859 | | Outcome | Active | | BioAssay | Primary biochemical high throughput screening assay to identify inhibitors of BCL2-related protein, long isoform (BCLXL). | | AID | 2129 | | BioAssay type | screening | | Target | bcl-xL [Homo sapiens] [gi:510901] | | PubMed | | | Data Table |  |
|
| 31 | [SID49666851] | Active | | | Counterscreen for MCL1 inhibitors: fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of BCL2-related protein, long isoform (BCLXL). [AID2166, Type: screening] | bcl-2-like protein 1 isoform 1 [Homo sapiens] [gi:20336335] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 49666851 | | CID | 9642859 | | Outcome | Active | | BioAssay | Counterscreen for MCL1 inhibitors: fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of BCL2-related protein, long isoform (BCLXL). | | AID | 2166 | | BioAssay type | screening | | Target | bcl-2-like protein 1 isoform 1 [Homo sapiens] [gi:20336335] | | PubMed | | | Data Table |  |
|
| 32 | [SID49666851] | Active | | | Counterscreen for MCL1 inhibitors: fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of BCL2-related protein, long isoform (BCLXL). [AID2166, Type: screening] | bcl-2-like protein 1 isoform 1 [Homo sapiens] [gi:20336335] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 49666851 | | CID | 9642859 | | Outcome | Active | | BioAssay | Counterscreen for MCL1 inhibitors: fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of BCL2-related protein, long isoform (BCLXL). | | AID | 2166 | | BioAssay type | screening | | Target | bcl-2-like protein 1 isoform 1 [Homo sapiens] [gi:20336335] | | PubMed | | | Data Table |  |
|
| 33 | [SID49666851] | Active | | | Counterscreen for MCL1 inhibitors: fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of BCL2-related protein, long isoform (BCLXL). [AID2166, Type: screening] | bcl-2-like protein 1 isoform 1 [Homo sapiens] [gi:20336335] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 49666851 | | CID | 9642859 | | Outcome | Active | | BioAssay | Counterscreen for MCL1 inhibitors: fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of BCL2-related protein, long isoform (BCLXL). | | AID | 2166 | | BioAssay type | screening | | Target | bcl-2-like protein 1 isoform 1 [Homo sapiens] [gi:20336335] | | PubMed | | | Data Table |  |
|
| 34 | [SID49666851] | Active | | | Fluorescence-based counterscreen for orexin 1 receptor (OX1R) antagonists: cell-based assay to identify antagonists of the parental CHO cell line [AID463079, Type: screening] | |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 49666851 | | CID | 9642859 | | Outcome | Active | | BioAssay | Fluorescence-based counterscreen for orexin 1 receptor (OX1R) antagonists: cell-based assay to identify antagonists of the parental CHO cell line | | AID | 463079 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 35 | [SID49666851] | Active | | | Fluorescence-based biochemical high throughput confirmation assay for activators of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF) [AID504383, Type: screening] | cardiac alpha tropomyosin [Sus scrofa] [gi:1927] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 49666851 | | CID | 9642859 | | Outcome | Active | | BioAssay | Fluorescence-based biochemical high throughput confirmation assay for activators of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF) | | AID | 504383 | | BioAssay type | screening | | Target | cardiac alpha tropomyosin [Sus scrofa] [gi:1927] | | PubMed | | | Data Table |  |
|
| 36 | [SID49666851] | Active | | | Fluorescence-based biochemical primary high throughput screening assay to identify activators of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF) [AID493008, Type: screening] | cardiac alpha tropomyosin [Sus scrofa] [gi:1927] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 49666851 | | CID | 9642859 | | Outcome | Active | | BioAssay | Fluorescence-based biochemical primary high throughput screening assay to identify activators of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF) | | AID | 493008 | | BioAssay type | screening | | Target | cardiac alpha tropomyosin [Sus scrofa] [gi:1927] | | PubMed | | | Data Table |  |
|
| 37 | [SID49666851] | Active | | | Epi-absorbance-based counterscreen assay for common VIM-2 and IMP-1 inhibitors: biochemical high throughput screening assay to identify inhibitors of TEM-1 serine-beta-lactamase. [AID2184, Type: screening] | Beta lactamase [Pseudomonas aeruginosa] [gi:114881106] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 49666851 | | CID | 9642859 | | Outcome | Active | | BioAssay | Epi-absorbance-based counterscreen assay for common VIM-2 and IMP-1 inhibitors: biochemical high throughput screening assay to identify inhibitors of TEM-1 serine-beta-lactamase. | | AID | 2184 | | BioAssay type | screening | | Target | Beta lactamase [Pseudomonas aeruginosa] [gi:114881106] | | PubMed | | | Data Table |  |
|
| 38 | [SID49666851] | Active | | | Epi-absorbance-based confirmation biochemical high throughput screening assay to identify selective inhibitors of VIM-2 metallo-beta-lactamase. [AID1860, Type: screening] | Beta lactamase [Pseudomonas aeruginosa] [gi:114881106] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 49666851 | | CID | 9642859 | | Outcome | Active | | BioAssay | Epi-absorbance-based confirmation biochemical high throughput screening assay to identify selective inhibitors of VIM-2 metallo-beta-lactamase. | | AID | 1860 | | BioAssay type | screening | | Target | Beta lactamase [Pseudomonas aeruginosa] [gi:114881106] | | PubMed | | | Data Table |  |
|
| 39 | [SID49666851] | Active | | | qHTS Assay for Inhibitors of the Six1/Eya2 Interaction [AID651725, Type: screening] | six1 [Homo sapiens] [gi:1246761] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 49666851 | | CID | 9642859 | | Outcome | Active | | BioAssay | qHTS Assay for Inhibitors of the Six1/Eya2 Interaction | | AID | 651725 | | BioAssay type | screening | | Target | six1 [Homo sapiens] [gi:1246761] | | PubMed | | | Data Table |  |
|
| 40 | [SID49666851] | Active | | | Primary biochemical high throughput screening assay to identify inhibitors of VIM-2 metallo-beta-lactamase [AID1527, Type: screening] | metallo beta-lactamase [Pseudomonas aeruginosa] [gi:7381449] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 49666851 | | CID | 9642859 | | Outcome | Active | | BioAssay | Primary biochemical high throughput screening assay to identify inhibitors of VIM-2 metallo-beta-lactamase | | AID | 1527 | | BioAssay type | screening | | Target | metallo beta-lactamase [Pseudomonas aeruginosa] [gi:7381449] | | PubMed | | | Data Table |  |
|
| 41 | [SID49666851] | Active | | | Primary biochemical high throughput screening assay to identify inhibitors of VIM-2 metallo-beta-lactamase [AID1527, Type: screening] | metallo beta-lactamase [Pseudomonas aeruginosa] [gi:7381449] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 49666851 | | CID | 9642859 | | Outcome | Active | | BioAssay | Primary biochemical high throughput screening assay to identify inhibitors of VIM-2 metallo-beta-lactamase | | AID | 1527 | | BioAssay type | screening | | Target | metallo beta-lactamase [Pseudomonas aeruginosa] [gi:7381449] | | PubMed | | | Data Table |  |
|
| 42 | [SID49666851] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 49666851 | | CID | 9642859 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 43 | [SID49666851] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 49666851 | | CID | 9642859 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 44 | [SID49666851] | Inactive | Potency | 4.1475 | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation [AID504834, Type: confirmatory] | |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 49666851 | | CID | 9642859 | | Outcome | Inactive | | Potency | 4.1475 [uM] | | BioAssay | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation | | AID | 504834 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 45 | [SID49666851] | Inactive | Potency | 12.5893 | qHTS of GLP-1 Receptor Inverse Agonists: Cytotox Screen [AID624418, Type: confirmatory] | |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 49666851 | | CID | 9642859 | | Outcome | Inactive | | Potency | 12.5893 [uM] | | BioAssay | qHTS of GLP-1 Receptor Inverse Agonists: Cytotox Screen | | AID | 624418 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 46 | [SID49666851] | Inactive | Potency | 19.9526 | qHTS for Inhibitors of ATXN expression [AID651635, Type: confirmatory] | ATXN2 gene product [Homo sapiens] [gi:171543895] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 49666851 | | CID | 9642859 | | Outcome | Inactive | | Potency | 19.9526 [uM] | | BioAssay | qHTS for Inhibitors of ATXN expression | | AID | 651635 | | BioAssay type | confirmatory | | Target | ATXN2 gene product [Homo sapiens] [gi:171543895] | | PubMed | | | Data Table |  |
|
| 47 | [SID49666851] | Inactive | Potency | 31.6228 | qHTS Assay for Identification of Novel General Anesthetics [AID485281, Type: confirmatory] | Chain A, Horse Spleen Apoferritin [gi:254220970] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 49666851 | | CID | 9642859 | | Outcome | Inactive | | Potency | 31.6228 [uM] | | BioAssay | qHTS Assay for Identification of Novel General Anesthetics | | AID | 485281 | | BioAssay type | confirmatory | | Target | Chain A, Horse Spleen Apoferritin [gi:254220970] | | PubMed | | | Data Table |  |
|
| 48 | [SID49666851] | Inactive | Potency | | qHTS Assay for Inhibitors of Leishmania Mexicana Pyruvate Kinase (LmPK) [AID1721, Type: confirmatory] | pyruvate kinase [Leishmania mexicana mexicana] [gi:290753097] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 49666851 | | CID | 9642859 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of Leishmania Mexicana Pyruvate Kinase (LmPK) | | AID | 1721 | | BioAssay type | confirmatory | | Target | pyruvate kinase [Leishmania mexicana mexicana] [gi:290753097] | | PubMed | | | Data Table |  |
|
| 49 | [SID49666851] | Inactive | Potency | | qHTS Assay for Activators of Leishmania Mexicana Pyruvate Kinase (LmPK) [AID1722, Type: confirmatory] | pyruvate kinase [Leishmania mexicana mexicana] [gi:290753097] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 49666851 | | CID | 9642859 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Activators of Leishmania Mexicana Pyruvate Kinase (LmPK) | | AID | 1722 | | BioAssay type | confirmatory | | Target | pyruvate kinase [Leishmania mexicana mexicana] [gi:290753097] | | PubMed | | | Data Table |  |
|
| 50 | [SID49666851] | Inactive | AC50 | | 24 hour HeLa Cytotox assay Measured in Cell-Based System Using Plate Reader - 2117-03_Inhibitor_Dose_CherryPick_Activity [AID504726, Type: confirmatory] | LANA [Human herpesvirus 8] [gi:312275222] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 49666851 | | CID | 9642859 | | Outcome | Inactive | | AC50 | [uM] | | BioAssay | 24 hour HeLa Cytotox assay Measured in Cell-Based System Using Plate Reader - 2117-03_Inhibitor_Dose_CherryPick_Activity | | AID | 504726 | | BioAssay type | confirmatory | | Target | LANA [Human herpesvirus 8] [gi:312275222] | | PubMed | | | Data Table |  |
|